(Q35212261)

7 August 2017

1 reference

title

Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations (English)

1 reference

7 August 2017

1 reference

1

S T Holgate

1 reference

7 August 2017

Giorgio Walter Canonica

2

object named as

G W Canonica

1 reference

7 August 2017

3

F E R Simons

1 reference

7 August 2017

M Taglialatela

4

1 reference

7 August 2017

M Tharp

5

1 reference

7 August 2017

H Timmerman

6

1 reference

7 August 2017

K Yanai

7

1 reference

7 August 2017

Consensus Group on New-Generation Antihistamines

8

1 reference

7 August 2017

1 September 2003

1 reference

Clinical & Experimental Allergy

7 August 2017

1 reference

7 August 2017

33

1 reference

7 August 2017

9

1 reference

7 August 2017

1305-1324

1 reference

Molecular properties and pharmacokinetic behavior of cetirizine, a zwitterionic H1-receptor antagonist.

7 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Constitutive activity of the histamine H(1) receptor reveals inverse agonism of histamine H(1) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Factors involved in the absence of sedative effects by the second-generation antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Second-generation antihistamines: the risk of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Allergy and allergic diseases. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Eotaxin levels and eosinophils in guinea pig broncho-alveolar lavage fluid are increased at the onset of a viral respiratory infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine-induced nasal response in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Clinical practice. Chronic urticaria and angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Cardiotoxic potential and CNS effects of first-generation antihistamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

The NHS: last act of a Greek tragedy? Government that puts money into redressing inequalities is worthy of support

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

In vivo occupation of cerebral histamine H1-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Lysine200 located in the fifth transmembrane domain of the histamine H1 receptor interacts with histamine but not with all H1 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Mechanism of the cardiotoxic actions of terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Effects of antihistamines in adult asthma: a meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

The potential of active metabolites of antihistamines in the management of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

Concepts basic to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01769.X

10.1046/J.1365-2222.2003.01769.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference